Police Arrest Trio for Possessing Banned Tobacco ProductsPolice Arrest Trio for Possessing Banned Tobacco Products Three individuals, including a delivery boy for an e-commerce giant, have been apprehended by the MBVV police in connection with the possession of banned tobacco products valued at Rs 1.65 lakh. On June 25, the suspects were observed acting suspiciously while carrying bags in Balaji Nagar. Upon further investigation, police discovered tobacco products in their possession. Senior Inspector Suryakant Naikwadi of Bhayander police station identified the arrested individuals as Sunny Chourasia, Satish Gupta, and Anil Chourasia. One of them is employed as a delivery boy for an unidentified e-commerce company. The trio has been charged with violating sections 188 (disobedience to public servant’s orders), 272 (food or drink adulteration), 273 (sale of harmful food or drink), and 328 (causing harm by poison or other means) of the Indian Penal Code, as well as relevant FDA regulations. The arrest serves as a reminder of the ongoing efforts to combat the illegal trade in harmful substances. The banned tobacco products allegedly possessed by the suspects pose a significant health risk to consumers.
Three persons, including the delivery boy of an e-commerce giant, were arrested for allegedly possessing banned tobacco products worth Rs 1.65 lakh, an official of the MBVV police station said on Saturday.
”On June 25, the three were found walking around suspiciously with bags in Balaji Nagar. During checking, we found tobacco products. Sunny Chourasia, Satish Gupta and Anil Chourasia were arrested. One of them is a delivery boy of an e-commerce company,” said senior inspector Suryakant Naikwadi of Bhayander police station.
They have been booked under sections 188 of the Indian Penal Code (disobedience to order duly promulgated by public servant), 272 (adulteration of food or drink intended for sale), 273 (sale of injurious food or drink) and 328 (causing harm by means of poison, etc., with intent to commit offence) and the FDA rules, he said.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
